Escherichia coli-associated granulomatous colitis in dogs treated according to antimicrobial susceptibility profiling.

Antimicrobial treatment guided by susceptibility profiling was associated with positive long-term outcomes in >80% of cases. Fluoroquinolone-resistance was widespread and not clonal. Further study is required to optimize treatment for dogs with MDR E coli-associated GC.